Profile data is unavailable for this security.
About the company
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
- Revenue in USD (TTM)36.58m
- Net income in USD-204.10m
- Incorporated2003
- Employees344.00
- LocationBionano Genomics Inc9640 TOWNE CENTRE DRIVE9640 TOWNE CENTRE DRIVESAN DIEGO 92121United StatesUSA
- Phone+1 (858) 888-7600
- Fax+1 (858) 888-7601
- Websitehttps://bionano.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outset Medical Inc | 116.43m | -159.18m | 30.95m | 480.00 | -- | 0.4511 | -- | 0.2658 | -3.14 | -3.14 | 2.29 | 1.32 | 0.3588 | 1.58 | 3.28 | 242,552.10 | -49.06 | -41.40 | -57.18 | -47.29 | 28.23 | 5.71 | -136.72 | -159.05 | 5.38 | -18.39 | 0.7417 | -- | 13.00 | 130.43 | -6.04 | -- | 14.27 | -- |
| IRIDEX Corp | 49.70m | -10.86m | 32.03m | 111.00 | -- | 7.52 | -- | 0.6444 | -0.6679 | -0.6679 | 3.06 | 0.2581 | 1.46 | 2.66 | 7.84 | 447,747.80 | -31.84 | -19.54 | -54.55 | -27.46 | 40.44 | 42.67 | -21.85 | -15.45 | 0.8599 | -- | 0.00 | -- | -8.96 | 4.02 | -26.81 | -- | -24.35 | -- |
| Icecure Medical Ltd | 3.34m | -13.69m | 32.19m | 71.00 | -- | 3.03 | -- | 9.65 | -0.2934 | -0.2934 | 0.0714 | 0.2143 | 0.1753 | 0.8436 | 15.06 | 46,985.91 | -71.93 | -54.89 | -92.10 | -68.66 | 40.32 | 49.87 | -410.22 | -313.19 | 2.54 | -- | 0.00 | -- | 4.67 | 23.50 | 13.70 | -- | 48.10 | -- |
| SANUWAVE Health Inc | 24.90m | -3.43m | 33.08m | 31.00 | -- | -- | -- | 1.33 | -0.0095 | -0.0095 | 0.0218 | -0.0335 | 1.24 | 3.90 | 8.34 | 803,064.50 | -17.07 | -136.54 | -- | -- | 71.57 | 69.13 | -13.79 | -189.60 | 0.0999 | 0.1199 | -- | -- | 21.84 | 61.61 | -150.72 | -- | -- | -- |
| Vicarious Surgical Inc | 0.00 | -61.02m | 34.56m | 131.00 | -- | 0.4795 | -- | -- | -10.77 | -10.77 | 0.00 | 12.22 | 0.00 | -- | -- | 0.00 | -61.68 | -- | -66.62 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1,478.15 | -- | -- | -- |
| United Health Products Inc | 0.00 | -1.84m | 34.73m | 6.00 | -- | -- | -- | -- | -0.0075 | -0.0075 | 0.00 | -0.0081 | 0.00 | 0.00 | -- | 0.00 | -662.95 | -6,446.86 | -- | -- | -- | 53.19 | -- | -132,561.20 | 0.0126 | -15.12 | -- | -- | -100.00 | -- | -55.45 | -- | -- | -- |
| Accelerate Diagnostics Inc | 12.23m | -37.91m | 34.81m | 134.00 | -- | -- | -- | 2.85 | -2.07 | -2.07 | 0.6853 | -1.47 | 0.3363 | 2.14 | 5.28 | 91,291.05 | -104.22 | -75.24 | -1,349.93 | -94.46 | 27.16 | 35.08 | -309.87 | -638.55 | 1.04 | -- | 6.38 | -- | -5.43 | 16.29 | 1.40 | -- | 0.7307 | -- |
| Vaso Corp | 80.33m | 2.26m | 35.08m | 300.00 | 12.96 | 1.31 | 11.19 | 0.4367 | 0.0154 | 0.0154 | 0.4571 | 0.1524 | 1.10 | 22.59 | 9.62 | 267,766.70 | 3.10 | 7.60 | 5.04 | 16.62 | 61.20 | 58.39 | 2.81 | 5.82 | 1.48 | -- | 0.0028 | -- | 2.18 | 1.84 | -57.46 | -- | -22.33 | -- |
| Movano Inc | 852.00k | -26.83m | 35.62m | 30.00 | -- | 2.12 | -- | 41.81 | -0.4527 | -0.4527 | 0.0131 | 0.1696 | 0.0444 | -- | 3.38 | 28,400.00 | -139.74 | -151.50 | -176.37 | -188.58 | -87.21 | -- | -3,149.06 | -- | 5.23 | -- | 0.0025 | -- | -- | -- | 3.45 | -- | 4.24 | -- |
| BioNano Genomics Inc | 36.58m | -204.10m | 36.12m | 344.00 | -- | 0.37 | -- | 0.9874 | -5.15 | -5.15 | 0.7496 | 1.14 | 0.1826 | 1.00 | 5.28 | 106,334.30 | -101.86 | -56.82 | -123.67 | -67.83 | 28.97 | 25.38 | -557.98 | -505.76 | 1.11 | -61.51 | 0.0455 | -- | 29.90 | 24.65 | -75.34 | -- | 38.51 | -- |
| Precision Optics Corporation Inc | 19.41m | -1.64m | 37.15m | 84.00 | -- | 3.15 | -- | 1.91 | -0.2706 | -0.2706 | 3.24 | 1.86 | 1.06 | 4.30 | 4.51 | 231,098.50 | -8.98 | -6.71 | -13.18 | -10.55 | 33.65 | 33.65 | -8.43 | -5.02 | 1.05 | -8.86 | 0.1982 | -- | 34.23 | 39.12 | 84.42 | -- | 19.39 | -- |
| Rapid Micro Biosystems Inc | 24.71m | -50.46m | 37.29m | 193.00 | -- | 0.3942 | -- | 1.51 | -1.17 | -1.17 | 0.5711 | 2.20 | 0.1778 | 1.33 | 5.58 | 128,036.30 | -36.30 | -- | -40.86 | -- | -14.22 | -- | -204.22 | -- | 4.62 | -- | 0.003 | -- | 31.44 | -- | 13.71 | -- | -- | -- |
| Apyx Medical Corp | 49.03m | -28.37m | 37.76m | 252.00 | -- | 2.56 | -- | 0.7702 | -0.8188 | -0.8188 | 1.42 | 0.4257 | 0.7672 | 1.82 | 3.96 | 194,567.50 | -44.55 | -25.24 | -58.21 | -29.97 | 61.90 | 66.11 | -58.08 | -46.00 | 4.45 | -7.79 | 0.693 | -- | 17.61 | 25.82 | 19.28 | -- | 7.99 | -- |
| T2 Biosystems Inc | 7.16m | -48.26m | 38.46m | 113.00 | -- | -- | -- | 5.37 | -10.70 | -10.70 | 1.09 | -0.3391 | 0.2435 | 2.82 | 5.41 | 63,398.23 | -164.01 | -106.01 | -- | -253.03 | -86.96 | -12.60 | -673.67 | -317.93 | 0.359 | -12.44 | 2.00 | -- | -67.75 | -7.29 | 19.66 | -- | -20.19 | -- |
| electroCore, Inc. | 21.28m | -14.23m | 38.69m | 68.00 | -- | 3.37 | -- | 1.82 | -2.19 | -2.19 | 3.25 | 1.78 | 1.16 | 1.41 | 54.85 | 312,955.90 | -77.78 | -70.73 | -125.05 | -88.96 | 83.61 | 75.81 | -66.84 | -352.82 | 2.12 | -- | 0.00 | -- | 86.57 | 74.42 | 15.02 | -- | -5.88 | -- |
| Co-Diagnostics Inc | 9.14m | -37.57m | 40.53m | 155.00 | -- | 0.5598 | -- | 4.44 | -1.27 | -1.27 | 0.3077 | 2.27 | 0.0944 | 1.19 | 11.08 | 58,948.20 | -38.83 | 5.77 | -41.04 | 6.15 | 59.83 | 82.24 | -411.19 | 10.94 | 8.81 | -- | 0.00 | 0.00 | -80.09 | 179.54 | -148.15 | -- | 101.27 | -- |
Data as of Sep 20 2024. Currency figures normalised to Bionano Genomics Inc's reporting currency: US Dollar USD
10.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 12 Aug 2024 | 5.00m | 5.81% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 2.08m | 2.42% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 607.44k | 0.71% |
| Geode Capital Management LLCas of 30 Jun 2024 | 599.22k | 0.70% |
| GMT Capital Corp.as of 30 Jun 2024 | 530.26k | 0.62% |
| Cetera Investment Advisers LLCas of 30 Jun 2024 | 156.63k | 0.18% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2024 | 131.35k | 0.15% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 113.99k | 0.13% |
| T. Rowe Price International Ltd.as of 30 Jun 2024 | 70.37k | 0.08% |
| Archford Capital Strategies LLCas of 30 Jun 2024 | 69.56k | 0.08% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
